data_FFO # _chem_comp.id FFO _chem_comp.name "N-[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid" _chem_comp.type NON-POLYMER _chem_comp.pdbx_type HETAIN _chem_comp.formula "C20 H23 N7 O7" _chem_comp.mon_nstd_parent_comp_id ? _chem_comp.pdbx_synonyms "[6S]-5-FORMYL-TETRAHYDROFOLATE; 6S-FOLINIC ACID" _chem_comp.pdbx_formal_charge 0 _chem_comp.pdbx_initial_date 1999-07-08 _chem_comp.pdbx_modified_date 2020-06-17 _chem_comp.pdbx_ambiguous_flag N _chem_comp.pdbx_release_status REL _chem_comp.pdbx_replaced_by ? _chem_comp.pdbx_replaces FOZ _chem_comp.formula_weight 473.439 _chem_comp.one_letter_code ? _chem_comp.three_letter_code FFO _chem_comp.pdbx_model_coordinates_details ? _chem_comp.pdbx_model_coordinates_missing_flag N _chem_comp.pdbx_ideal_coordinates_details Corina _chem_comp.pdbx_ideal_coordinates_missing_flag N _chem_comp.pdbx_model_coordinates_db_code 1JOL _chem_comp.pdbx_subcomponent_list ? _chem_comp.pdbx_processing_site RCSB # loop_ _chem_comp_atom.comp_id _chem_comp_atom.atom_id _chem_comp_atom.alt_atom_id _chem_comp_atom.type_symbol _chem_comp_atom.charge _chem_comp_atom.pdbx_align _chem_comp_atom.pdbx_aromatic_flag _chem_comp_atom.pdbx_leaving_atom_flag _chem_comp_atom.pdbx_stereo_config _chem_comp_atom.pdbx_backbone_atom_flag _chem_comp_atom.pdbx_n_terminal_atom_flag _chem_comp_atom.pdbx_c_terminal_atom_flag _chem_comp_atom.model_Cartn_x _chem_comp_atom.model_Cartn_y _chem_comp_atom.model_Cartn_z _chem_comp_atom.pdbx_model_Cartn_x_ideal _chem_comp_atom.pdbx_model_Cartn_y_ideal _chem_comp_atom.pdbx_model_Cartn_z_ideal _chem_comp_atom.pdbx_component_atom_id _chem_comp_atom.pdbx_component_comp_id _chem_comp_atom.pdbx_ordinal FFO N1 N1 N 0 1 N N N N N N 22.811 57.344 22.675 5.130 -2.520 0.687 N1 FFO 1 FFO C2 C2 C 0 1 N N N N N N 23.612 57.816 23.619 5.410 -2.900 -0.542 C2 FFO 2 FFO NA2 NA2 N 0 1 N N N N N N 24.820 58.207 23.361 5.634 -4.229 -0.796 NA2 FFO 3 FFO N3 N3 N 0 1 N N N N N N 23.109 57.950 24.948 5.480 -2.008 -1.567 N3 FFO 4 FFO C4 C4 C 0 1 N N N N N N 21.849 57.610 25.298 5.265 -0.694 -1.339 C4 FFO 5 FFO O4 O4 O 0 1 N N N N N N 21.467 57.790 26.483 5.328 0.117 -2.251 O4 FFO 6 FFO C4A C4A C 0 1 N N N N N N 21.025 57.047 24.206 4.968 -0.282 -0.035 C4A FFO 7 FFO N5 N5 N 0 1 N N N N N N 19.686 56.703 24.383 4.737 1.077 0.258 N5 FFO 8 FFO C6 C6 C 0 1 N N S N N N 18.869 56.860 23.284 4.091 1.420 1.535 C6 FFO 9 FFO C7 C7 C 0 1 N N N N N N 19.539 56.325 22.122 4.738 0.571 2.639 C7 FFO 10 FFO N8 N8 N 0 1 N N N N N N 20.782 56.695 21.823 4.606 -0.846 2.270 N8 FFO 11 FFO C8A C8A C 0 1 N N N N N N 21.526 56.951 22.935 4.904 -1.234 0.975 C8A FFO 12 FFO C9 C9 C 0 1 N N N N N N 18.517 58.327 23.216 2.594 1.112 1.456 C9 FFO 13 FFO N10 N10 N 0 1 N N N N N N 17.890 58.851 24.497 2.012 1.807 0.306 N10 FFO 14 FFO C11 C11 C 0 1 Y N N N N N 18.383 62.980 25.267 -2.047 1.418 -0.526 C11 FFO 15 FFO C12 C12 C 0 1 Y N N N N N 17.793 62.116 26.204 -1.237 2.213 -1.344 C12 FFO 16 FFO C13 C13 C 0 1 Y N N N N N 17.612 60.763 25.996 0.105 2.339 -1.066 C13 FFO 17 FFO C14 C14 C 0 1 Y N N N N N 18.048 60.222 24.759 0.656 1.678 0.028 C14 FFO 18 FFO C15 C15 C 0 1 Y N N N N N 18.623 61.019 23.855 -0.148 0.886 0.844 C15 FFO 19 FFO C16 C16 C 0 1 Y N N N N N 18.789 62.389 24.083 -1.490 0.755 0.571 C16 FFO 20 FFO C C C 0 1 N N N N N N 18.530 64.429 25.528 -3.487 1.285 -0.818 C FFO 21 FFO O O O 0 1 N N N N N N 17.709 64.983 26.299 -3.971 1.867 -1.770 O FFO 22 FFO N N N 0 1 N N N N N N 19.454 65.177 24.895 -4.266 0.519 -0.029 N FFO 23 FFO CA CA C 0 1 N N S N N N 19.628 66.682 24.964 -5.696 0.387 -0.318 CA FFO 24 FFO CB CB C 0 1 N N N N N N 20.805 67.012 25.954 -6.214 -0.932 0.260 CB FFO 25 FFO CG CG C 0 1 N N N N N N 20.178 68.246 26.784 -5.545 -2.103 -0.463 CG FFO 26 FFO CD CD C 0 1 N N N N N N 20.578 67.593 28.092 -6.055 -3.401 0.106 CD FFO 27 FFO OE1 OE1 O 0 1 N N N N N N 19.628 67.510 28.923 -6.869 -3.391 0.998 OE1 FFO 28 FFO OE2 OE2 O 0 1 N N N N N N 21.682 67.020 27.987 -5.604 -4.569 -0.378 OE2 FFO 29 FFO CT CT C 0 1 N N N N N N 19.928 67.028 23.553 -6.443 1.537 0.306 CT FFO 30 FFO O1 O1 O 0 1 N N N N N N 20.407 66.117 22.813 -5.843 2.380 0.929 O1 FFO 31 FFO O2 O2 O 0 1 N N N N N N 19.533 68.152 23.192 -7.776 1.625 0.171 O2 FFO 32 FFO C5A C5A C 0 1 N N N N N N 18.886 56.223 25.315 5.101 2.041 -0.611 C5A FFO 33 FFO O5B O5B O 0 1 N N N N N N 19.295 55.256 25.947 4.808 3.198 -0.391 O5B FFO 34 FFO HN21 HN21 H 0 0 N N N N N N 25.173 58.157 22.427 5.587 -4.875 -0.075 HN21 FFO 35 FFO HN22 HN22 H 0 0 N N N N N N 25.400 58.558 24.096 5.841 -4.522 -1.697 HN22 FFO 36 FFO H6 H6 H 0 1 N N N N N N 17.924 56.301 23.344 4.238 2.478 1.750 H6 FFO 37 FFO H7 H7 H 0 1 N N N N N N 19.577 55.236 22.271 5.792 0.831 2.731 H7 FFO 38 FFO H91 H91 H 0 1 N N N N N N 19.440 58.895 23.027 2.450 0.037 1.342 H91 FFO 39 FFO H92 H92 H 0 1 N N N N N N 17.798 58.471 22.396 2.105 1.449 2.370 H92 FFO 40 FFO HN0 HN0 H 0 1 N N N N N N 16.908 58.673 24.439 2.573 2.358 -0.263 HN0 FFO 41 FFO H12 H12 H 0 1 N N N N N N 17.461 62.535 27.143 -1.664 2.726 -2.193 H12 FFO 42 FFO H13 H13 H 0 1 N N N N N N 17.154 60.138 26.749 0.731 2.953 -1.697 H13 FFO 43 FFO H15 H15 H 0 1 N N N N N N 18.969 60.595 22.924 0.283 0.374 1.692 H15 FFO 44 FFO H16 H16 H 0 1 N N N N N N 19.244 63.000 23.318 -2.113 0.141 1.205 H16 FFO 45 FFO HN HN H 0 1 N N N N N N 20.100 64.683 24.312 -3.880 0.055 0.730 HN FFO 46 FFO HA HA H 0 1 N N N N N N 18.765 67.249 25.343 -5.851 0.396 -1.397 HA FFO 47 FFO HB1 HB1 H 0 1 N N N N N N 21.059 66.159 26.601 -5.979 -0.979 1.323 HB1 FFO 48 FFO HB2 HB2 H 0 1 N N N N N N 21.730 67.289 25.427 -7.293 -0.989 0.123 HB2 FFO 49 FFO HG1 HG1 H 0 1 N N N N N N 20.609 69.238 26.583 -5.779 -2.055 -1.526 HG1 FFO 50 FFO HG2 HG2 H 0 1 N N N N N N 19.103 68.433 26.641 -4.465 -2.045 -0.326 HG2 FFO 51 FFO HOE2 HOE2 H 0 0 N N N N N N 21.788 66.402 28.701 -5.960 -5.376 0.019 HOE2 FFO 52 FFO HO2 HO2 H 0 1 N N N N N N 19.642 68.240 22.252 -8.211 2.380 0.589 HO2 FFO 53 FFO H5A H5A H 0 1 N N N N N N 17.918 56.660 25.512 5.652 1.784 -1.503 H5A FFO 54 FFO H22 H22 H 0 1 N N N N N N 23.718 58.313 25.653 5.686 -2.316 -2.464 H22 FFO 55 FFO H23 H23 H 0 1 N N N N N N 18.923 56.616 21.259 4.230 0.752 3.587 H23 FFO 56 FFO H24 H24 H 0 1 N N N N N N 21.219 55.956 21.311 4.315 -1.500 2.925 H24 FFO 57 # loop_ _chem_comp_bond.comp_id _chem_comp_bond.atom_id_1 _chem_comp_bond.atom_id_2 _chem_comp_bond.value_order _chem_comp_bond.pdbx_aromatic_flag _chem_comp_bond.pdbx_stereo_config _chem_comp_bond.pdbx_ordinal FFO N1 C2 DOUB N N 1 FFO N1 C8A SING N N 2 FFO C2 NA2 SING N N 3 FFO C2 N3 SING N N 4 FFO NA2 HN21 SING N N 5 FFO NA2 HN22 SING N N 6 FFO N3 C4 SING N N 7 FFO N3 H22 SING N N 8 FFO C4 O4 DOUB N N 9 FFO C4 C4A SING N N 10 FFO C4A N5 SING N N 11 FFO C4A C8A DOUB N N 12 FFO N5 C6 SING N N 13 FFO N5 C5A SING N N 14 FFO C6 C7 SING N N 15 FFO C6 C9 SING N N 16 FFO C6 H6 SING N N 17 FFO C7 N8 SING N N 18 FFO C7 H7 SING N N 19 FFO C7 H23 SING N N 20 FFO N8 C8A SING N N 21 FFO N8 H24 SING N N 22 FFO C9 N10 SING N N 23 FFO C9 H91 SING N N 24 FFO C9 H92 SING N N 25 FFO N10 C14 SING N N 26 FFO N10 HN0 SING N N 27 FFO C11 C12 DOUB Y N 28 FFO C11 C16 SING Y N 29 FFO C11 C SING N N 30 FFO C12 C13 SING Y N 31 FFO C12 H12 SING N N 32 FFO C13 C14 DOUB Y N 33 FFO C13 H13 SING N N 34 FFO C14 C15 SING Y N 35 FFO C15 C16 DOUB Y N 36 FFO C15 H15 SING N N 37 FFO C16 H16 SING N N 38 FFO C O DOUB N N 39 FFO C N SING N N 40 FFO N CA SING N N 41 FFO N HN SING N N 42 FFO CA CB SING N N 43 FFO CA CT SING N N 44 FFO CA HA SING N N 45 FFO CB CG SING N N 46 FFO CB HB1 SING N N 47 FFO CB HB2 SING N N 48 FFO CG CD SING N N 49 FFO CG HG1 SING N N 50 FFO CG HG2 SING N N 51 FFO CD OE1 DOUB N N 52 FFO CD OE2 SING N N 53 FFO OE2 HOE2 SING N N 54 FFO CT O1 DOUB N N 55 FFO CT O2 SING N N 56 FFO O2 HO2 SING N N 57 FFO C5A O5B DOUB N N 58 FFO C5A H5A SING N N 59 # loop_ _pdbx_chem_comp_descriptor.comp_id _pdbx_chem_comp_descriptor.type _pdbx_chem_comp_descriptor.program _pdbx_chem_comp_descriptor.program_version _pdbx_chem_comp_descriptor.descriptor FFO SMILES ACDLabs 12.01 O=C(O)C(NC(=O)c1ccc(cc1)NCC2N(C=O)C=3C(=O)NC(=NC=3NC2)N)CCC(=O)O FFO InChI InChI 1.03 InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12-,13-/m0/s1 FFO InChIKey InChI 1.03 VVIAGPKUTFNRDU-STQMWFEESA-N FFO SMILES_CANONICAL CACTVS 3.370 NC1=NC2=C(N(C=O)[C@@H](CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CN2)C(=O)N1 FFO SMILES CACTVS 3.370 NC1=NC2=C(N(C=O)[CH](CNc3ccc(cc3)C(=O)N[CH](CCC(O)=O)C(O)=O)CN2)C(=O)N1 FFO SMILES_CANONICAL "OpenEye OEToolkits" 1.7.2 c1cc(ccc1C(=O)NC(CCC(=O)O)C(=O)O)NCC2CNC3=C(N2C=O)C(=O)NC(=N3)N FFO SMILES "OpenEye OEToolkits" 1.7.2 c1cc(ccc1C(=O)NC(CCC(=O)O)C(=O)O)NCC2CNC3=C(N2C=O)C(=O)NC(=N3)N # loop_ _pdbx_chem_comp_identifier.comp_id _pdbx_chem_comp_identifier.type _pdbx_chem_comp_identifier.program _pdbx_chem_comp_identifier.program_version _pdbx_chem_comp_identifier.identifier FFO "SYSTEMATIC NAME" ACDLabs 12.01 "N-[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid" FFO "SYSTEMATIC NAME" "OpenEye OEToolkits" 1.7.2 "2-[[4-[(2-azanyl-5-methanoyl-4-oxidanylidene-3,6,7,8-tetrahydropteridin-6-yl)methylamino]phenyl]carbonylamino]pentanedioic acid" # loop_ _pdbx_chem_comp_audit.comp_id _pdbx_chem_comp_audit.action_type _pdbx_chem_comp_audit.date _pdbx_chem_comp_audit.processing_site FFO 'Create component' 1999-07-08 RCSB FFO 'Modify descriptor' 2011-06-04 RCSB FFO 'Modify formula' 2011-09-06 RCSB FFO 'Other modification' 2019-11-12 RCSB FFO 'Modify synonyms' 2020-06-05 PDBE # loop_ _pdbx_chem_comp_synonyms.ordinal _pdbx_chem_comp_synonyms.comp_id _pdbx_chem_comp_synonyms.name _pdbx_chem_comp_synonyms.provenance _pdbx_chem_comp_synonyms.type 1 FFO "[6S]-5-FORMYL-TETRAHYDROFOLATE" ? ? 2 FFO "6S-FOLINIC ACID" ? ? # _pdbe_chem_comp_drugbank_details.comp_id FFO _pdbe_chem_comp_drugbank_details.drugbank_id DB11596 _pdbe_chem_comp_drugbank_details.type 'small molecule' _pdbe_chem_comp_drugbank_details.name Levoleucovorin _pdbe_chem_comp_drugbank_details.description 'Levoleucovorin is the enantiomerically active form of Folinic Acid (also known as 5-formyl tetrahydrofolic acid or leucovorin). Commercially available leucovorin is composed of a 1:1 racemic mixture of the dextrorotary and levorotary isomers, while levoleucovorin contains only the pharmacologically active levo-isomer. In vitro, the levo-isomer has been shown to be rapidly converted to the biologically available methyl-tetrahydrofolate form while the dextro form is slowly excreted by the kidneys. Despite this difference in activity, the two commercially available forms have been shown to be pharmacokinetically identical and may be used interchangeably with limited differences in efficacy or side effects (Kovoor et al, 2009). As folate analogs, levoleucovorin and leucovorin are both used to counteract the toxic effects of folic acid antagonists, such as methotrexate, which act by inhibiting the enzyme dihydrofolate reductase (DHFR). They are indicated for use as rescue therapy following use of high-dose methotrexate in the treatment of osteosarcoma or for diminishing the toxicity associated with inadvertent overdosage of folic acid antagonists. Levoleucovorin, as the product Fusilev (FDA), has an additional indication for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer. Folic acid is an essential B vitamin required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. However, in order to function in this role, it must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted when high-dose methotrexate is used for cancer therapy. As methotrexate functions as a DHFR inhibitor to prevent DNA synthesis in rapidly dividing cells, it also prevents the formation of DHF and THF. This results in a deficiency of coenzymes and a resultant buildup of toxic substances that are responsible for numerous adverse side effects of methotrexate therapy. As levoleucovorin and leucovorin are analogs of tetrahydrofolate (THF), they are able to bypass DHFR reduction and act as a cellular replacement for the co-factor THF, thereby preventing these toxic side effects.' _pdbe_chem_comp_drugbank_details.cas_number 68538-85-2 _pdbe_chem_comp_drugbank_details.mechanism_of_action 'Folic acid is an essential B vitamin required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. However, in order to function in this role, it must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted when high-dose methotrexate is used for cancer therapy. As methotrexate functions as a DHFR inhibitor to prevent DNA synthesis in rapidly dividing cells, it also prevents the formation of DHF and THF. This results in a deficiency of coenzymes and a resultant buildup of toxic substances that are responsible for numerous adverse side effects of methotrexate therapy. As levoleucovorin and leucovorin are analogs of tetrahydrofolate (THF), they are able to bypass DHFR reduction and act as a cellular replacement for the co-factor THF, thereby preventing these toxic side effects.' # loop_ _pdbe_chem_comp_synonyms.comp_id _pdbe_chem_comp_synonyms.name _pdbe_chem_comp_synonyms.provenance _pdbe_chem_comp_synonyms.type FFO '[6S]-5-FORMYL-TETRAHYDROFOLATE' wwPDB ? FFO '6S-FOLINIC ACID' wwPDB ? FFO '(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid' DrugBank ? FFO '(6S)-5-formyltetrahydrofolic acid' DrugBank ? FFO '(6S)-Folinic acid' DrugBank ? FFO (6S)-Leucovorin DrugBank ? FFO (S)-Leucovorin DrugBank ? FFO 'Citrovorum factor' DrugBank ? FFO 'L-Folinic acid' DrugBank ? FFO Levofolene DrugBank ? FFO 'Levofolinic acid' DrugBank ? FFO 'N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid' DrugBank ? # _pdbe_chem_comp_drugbank_classification.comp_id FFO _pdbe_chem_comp_drugbank_classification.drugbank_id DB11596 _pdbe_chem_comp_drugbank_classification.parent 'Tetrahydrofolic acids' _pdbe_chem_comp_drugbank_classification.kingdom 'Organic compounds' _pdbe_chem_comp_drugbank_classification.class 'Pteridines and derivatives' _pdbe_chem_comp_drugbank_classification.superclass 'Organoheterocyclic compounds' _pdbe_chem_comp_drugbank_classification.description 'This compound belongs to the class of organic compounds known as tetrahydrofolic acids. These are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit.' # _pdbe_chem_comp_drugbank_targets.comp_id FFO _pdbe_chem_comp_drugbank_targets.drugbank_id DB11596 _pdbe_chem_comp_drugbank_targets.name 'Serine hydroxymethyltransferase' _pdbe_chem_comp_drugbank_targets.organism 'Shigella flexneri' _pdbe_chem_comp_drugbank_targets.uniprot_id P0A827 _pdbe_chem_comp_drugbank_targets.pharmacologically_active unknown _pdbe_chem_comp_drugbank_targets.ordinal 1 # loop_ _software.name _software.version _software.description rdkit 2023.03.3 'Core functionality.' pdbeccdutils 0.8.4 'Wrapper to provide 2D templates and molecular fragments.' # loop_ _pdbe_chem_comp_atom_depiction.comp_id _pdbe_chem_comp_atom_depiction.atom_id _pdbe_chem_comp_atom_depiction.element _pdbe_chem_comp_atom_depiction.model_Cartn_x _pdbe_chem_comp_atom_depiction.model_Cartn_y _pdbe_chem_comp_atom_depiction.pdbx_ordinal FFO N1 N 20.735 4.901 1 FFO C2 C 22.094 4.130 2 FFO NA2 N 23.390 4.885 3 FFO N3 N 22.094 2.568 4 FFO C4 C 20.735 1.797 5 FFO O4 O 20.717 0.297 6 FFO C4A C 19.394 2.599 7 FFO N5 N 18.095 1.849 8 FFO C6 C 16.796 2.599 9 FFO C7 C 16.796 4.099 10 FFO N8 N 18.095 4.849 11 FFO C8A C 19.394 4.099 12 FFO C9 C 15.497 1.849 13 FFO N10 N 14.198 2.599 14 FFO C11 C 10.301 0.349 15 FFO C12 C 10.301 1.849 16 FFO C13 C 11.600 2.599 17 FFO C14 C 12.899 1.849 18 FFO C15 C 12.899 0.349 19 FFO C16 C 11.600 -0.401 20 FFO C C 9.002 -0.401 21 FFO O O 9.002 -1.901 22 FFO N N 7.702 0.349 23 FFO CA C 6.404 -0.401 24 FFO CB C 6.404 -1.901 25 FFO CG C 5.104 -2.651 26 FFO CD C 5.104 -4.151 27 FFO OE1 O 3.805 -4.901 28 FFO OE2 O 6.404 -4.901 29 FFO CT C 5.104 0.349 30 FFO O1 O 3.805 -0.401 31 FFO O2 O 5.104 1.849 32 FFO C5A C 18.095 0.349 33 FFO O5B O 16.796 -0.401 34 # loop_ _pdbe_chem_comp_bond_depiction.comp_id _pdbe_chem_comp_bond_depiction.atom_id_1 _pdbe_chem_comp_bond_depiction.atom_id_2 _pdbe_chem_comp_bond_depiction.value_order _pdbe_chem_comp_bond_depiction.bond_dir _pdbe_chem_comp_bond_depiction.pdbx_ordinal FFO N1 C2 DOUBLE NONE 1 FFO N1 C8A SINGLE NONE 2 FFO C2 NA2 SINGLE NONE 3 FFO C2 N3 SINGLE NONE 4 FFO N3 C4 SINGLE NONE 5 FFO C4 O4 DOUBLE NONE 6 FFO C4 C4A SINGLE NONE 7 FFO C4A N5 SINGLE NONE 8 FFO C4A C8A DOUBLE NONE 9 FFO N5 C6 SINGLE NONE 10 FFO N5 C5A SINGLE NONE 11 FFO C6 C7 SINGLE NONE 12 FFO C6 C9 SINGLE BEGINWEDGE 13 FFO C7 N8 SINGLE NONE 14 FFO N8 C8A SINGLE NONE 15 FFO C9 N10 SINGLE NONE 16 FFO N10 C14 SINGLE NONE 17 FFO C11 C12 DOUBLE NONE 18 FFO C11 C16 SINGLE NONE 19 FFO C11 C SINGLE NONE 20 FFO C12 C13 SINGLE NONE 21 FFO C13 C14 DOUBLE NONE 22 FFO C14 C15 SINGLE NONE 23 FFO C15 C16 DOUBLE NONE 24 FFO C O DOUBLE NONE 25 FFO C N SINGLE NONE 26 FFO N CA SINGLE NONE 27 FFO CA CB SINGLE BEGINWEDGE 28 FFO CA CT SINGLE NONE 29 FFO CB CG SINGLE NONE 30 FFO CG CD SINGLE NONE 31 FFO CD OE1 DOUBLE NONE 32 FFO CD OE2 SINGLE NONE 33 FFO CT O1 DOUBLE NONE 34 FFO CT O2 SINGLE NONE 35 FFO C5A O5B DOUBLE NONE 36 # loop_ _pdbe_chem_comp_substructure.comp_id _pdbe_chem_comp_substructure.substructure_name _pdbe_chem_comp_substructure.id _pdbe_chem_comp_substructure.substructure_type _pdbe_chem_comp_substructure.substructure_smiles _pdbe_chem_comp_substructure.substructure_inchis _pdbe_chem_comp_substructure.substructure_inchikeys FFO MurckoScaffold S1 scaffold 'O=c1[nH]cnc2c1N[C@@H](CNc1ccccc1)CN2' InChI=1S/C13H15N5O/c19-13-11-12(16-8-17-13)15-7-10(18-11)6-14-9-4-2-1-3-5-9/h1-5,8,10,14,18H,6-7H2,(H2,15,16,17,19)/t10-/m0/s1 HSISPQXNAMHQIC-JTQLQIEISA-N FFO amide F1 fragment CC(N)=O InChI=1S/C2H5NO/c1-2(3)4/h1H3,(H2,3,4) DLFVBJFMPXGRIB-UHFFFAOYSA-N FFO peptide F2 fragment NCC=O InChI=1S/C2H5NO/c3-1-2-4/h2H,1,3H2 LYIIBVSRGJSHAV-UHFFFAOYSA-N FFO phenyl F3 fragment c1ccccc1 InChI=1S/C6H6/c1-2-4-6-5-3-1/h1-6H UHOVQNZJYSORNB-UHFFFAOYSA-N FFO pyrimidine F4 fragment c1cncnc1 InChI=1S/C4H4N2/c1-2-5-4-6-3-1/h1-4H CZPWVGJYEJSRLH-UHFFFAOYSA-N # loop_ _pdbe_chem_comp_substructure_mapping.comp_id _pdbe_chem_comp_substructure_mapping.atom_id _pdbe_chem_comp_substructure_mapping.substructure_id _pdbe_chem_comp_substructure_mapping.substructure_ordinal FFO N1 S1 1 FFO C2 S1 1 FFO N3 S1 1 FFO C4 S1 1 FFO O4 S1 1 FFO C4A S1 1 FFO N5 S1 1 FFO C6 S1 1 FFO C7 S1 1 FFO N8 S1 1 FFO C8A S1 1 FFO C9 S1 1 FFO N10 S1 1 FFO C11 S1 1 FFO C12 S1 1 FFO C13 S1 1 FFO C14 S1 1 FFO C15 S1 1 FFO C16 S1 1 FFO N F1 1 FFO C F1 1 FFO O F1 1 FFO C11 F1 1 FFO O1 F2 1 FFO CT F2 1 FFO CA F2 1 FFO N F2 1 FFO C11 F3 1 FFO C12 F3 1 FFO C13 F3 1 FFO C14 F3 1 FFO C15 F3 1 FFO C16 F3 1 FFO C4A F4 1 FFO C4 F4 1 FFO N3 F4 1 FFO C2 F4 1 FFO N1 F4 1 FFO C8A F4 1 # _pdbe_chem_comp_rdkit_properties.comp_id FFO _pdbe_chem_comp_rdkit_properties.exactmw 473.166 _pdbe_chem_comp_rdkit_properties.amw 473.446 _pdbe_chem_comp_rdkit_properties.lipinskiHBA 14 _pdbe_chem_comp_rdkit_properties.lipinskiHBD 8 _pdbe_chem_comp_rdkit_properties.NumRotatableBonds 10 _pdbe_chem_comp_rdkit_properties.NumHBD 7 _pdbe_chem_comp_rdkit_properties.NumHBA 11 _pdbe_chem_comp_rdkit_properties.NumHeavyAtoms 34 _pdbe_chem_comp_rdkit_properties.NumAtoms 57 _pdbe_chem_comp_rdkit_properties.NumHeteroatoms 14 _pdbe_chem_comp_rdkit_properties.NumAmideBonds 2 _pdbe_chem_comp_rdkit_properties.FractionCSP3 0.300 _pdbe_chem_comp_rdkit_properties.NumRings 3 _pdbe_chem_comp_rdkit_properties.NumAromaticRings 2 _pdbe_chem_comp_rdkit_properties.NumAliphaticRings 1 _pdbe_chem_comp_rdkit_properties.NumSaturatedRings 0 _pdbe_chem_comp_rdkit_properties.NumHeterocycles 2 _pdbe_chem_comp_rdkit_properties.NumAromaticHeterocycles 1 _pdbe_chem_comp_rdkit_properties.NumSaturatedHeterocycles 0 _pdbe_chem_comp_rdkit_properties.NumAliphaticHeterocycles 1 _pdbe_chem_comp_rdkit_properties.NumSpiroAtoms 0 _pdbe_chem_comp_rdkit_properties.NumBridgeheadAtoms 0 _pdbe_chem_comp_rdkit_properties.NumAtomStereoCenters 2 _pdbe_chem_comp_rdkit_properties.NumUnspecifiedAtomStereoCenters 0 _pdbe_chem_comp_rdkit_properties.labuteASA 224.553 _pdbe_chem_comp_rdkit_properties.tpsa 219.840 _pdbe_chem_comp_rdkit_properties.CrippenClogP -1.408 _pdbe_chem_comp_rdkit_properties.CrippenMR 117.328 _pdbe_chem_comp_rdkit_properties.chi0v 15.988 _pdbe_chem_comp_rdkit_properties.chi1v 8.309 _pdbe_chem_comp_rdkit_properties.chi2v 3.417 _pdbe_chem_comp_rdkit_properties.chi3v 3.417 _pdbe_chem_comp_rdkit_properties.chi4v 2.090 _pdbe_chem_comp_rdkit_properties.chi0n 38.988 _pdbe_chem_comp_rdkit_properties.chi1n 19.309 _pdbe_chem_comp_rdkit_properties.chi2n 3.417 _pdbe_chem_comp_rdkit_properties.chi3n 3.417 _pdbe_chem_comp_rdkit_properties.chi4n 2.090 _pdbe_chem_comp_rdkit_properties.hallKierAlpha -4.620 _pdbe_chem_comp_rdkit_properties.kappa1 8.002 _pdbe_chem_comp_rdkit_properties.kappa2 10.331 _pdbe_chem_comp_rdkit_properties.kappa3 5.591 _pdbe_chem_comp_rdkit_properties.Phi 2.431 # loop_ _pdbe_chem_comp_external_mappings.comp_id _pdbe_chem_comp_external_mappings.source _pdbe_chem_comp_external_mappings.resource _pdbe_chem_comp_external_mappings.resource_id FFO UniChem ChEMBL CHEMBL1908841 FFO UniChem DrugBank DB11596 FFO UniChem PDBe FFO FFO UniChem ChEBI 63606 FFO UniChem ZINC ZINC000009212427 FFO UniChem fdasrs 990S25980Y FFO UniChem SureChEMBL SCHEMBL16946130 FFO UniChem SureChEMBL SCHEMBL571901 FFO UniChem HMDB HMDB0001562 FFO UniChem 'PubChem TPHARMA' 14809717 FFO UniChem 'PubChem TPHARMA' 15318605 FFO UniChem 'PubChem TPHARMA' 16004520 FFO UniChem 'PubChem TPHARMA' 49708539 FFO UniChem PubChem 135398559 FFO UniChem NMRShiftDB 60020503 FFO UniChem ACTor 121451-09-0 FFO UniChem ACTor 58-05-9 FFO UniChem Nikkaji J185.512C FFO UniChem BindingDb 286 FFO UniChem 'EPA CompTox Dashboard' DTXSID4023204 FFO UniChem DrugCentral 4384 FFO UniChem MetaboLights MTBLC63606 FFO UniChem BRENDA 120752 FFO UniChem BRENDA 120755 FFO UniChem BRENDA 12733 FFO UniChem BRENDA 16045 FFO UniChem BRENDA 1611 FFO UniChem BRENDA 17545 FFO UniChem BRENDA 247162 FFO UniChem BRENDA 43539 FFO UniChem BRENDA 93399 FFO UniChem DailyMed LEVOLEUCOVORIN FFO UniChem ClinicalTrials 'CALCIUM LEVOFOLINATE' FFO UniChem ClinicalTrials 'CL 307,782' FFO UniChem ClinicalTrials CL-307782 FFO UniChem ClinicalTrials ELVORINE FFO UniChem ClinicalTrials ISOVORIN FFO UniChem ClinicalTrials KHAPZORY FFO UniChem ClinicalTrials 'LEVOFOLINATE CALCIUM' FFO UniChem ClinicalTrials 'LEVOFOLINIC ACID' FFO UniChem ClinicalTrials LEVOLEUCOVORIN FFO UniChem ClinicalTrials 'LEVOLEUCOVORIN CALCIUM' FFO UniChem rxnorm KHAPZORY FFO UniChem rxnorm LEVOLEUCOVORIN FFO UniChem rxnorm 'LEVOLEUCOVORIN CALCIUM' FFO UniChem 'Probes And Drugs' PD009871 # loop_ _pdbe_chem_comp_rdkit_conformer.comp_id _pdbe_chem_comp_rdkit_conformer.atom_id _pdbe_chem_comp_rdkit_conformer.Cartn_x_rdkit _pdbe_chem_comp_rdkit_conformer.Cartn_y_rdkit _pdbe_chem_comp_rdkit_conformer.Cartn_z_rdkit _pdbe_chem_comp_rdkit_conformer.rdkit_method _pdbe_chem_comp_rdkit_conformer.rdkit_ordinal FFO N1 -5.899 -0.042 -2.801 ETKDGv3 1 FFO C2 -6.752 0.927 -2.965 ETKDGv3 2 FFO NA2 -7.317 1.164 -4.254 ETKDGv3 3 FFO N3 -7.118 1.756 -1.856 ETKDGv3 4 FFO C4 -6.524 1.515 -0.579 ETKDGv3 5 FFO O4 -6.778 2.282 0.387 ETKDGv3 6 FFO C4A -5.586 0.380 -0.433 ETKDGv3 7 FFO N5 -4.969 0.049 0.832 ETKDGv3 8 FFO C6 -3.648 -0.623 0.771 ETKDGv3 9 FFO C7 -3.766 -1.835 -0.172 ETKDGv3 10 FFO N8 -4.353 -1.424 -1.446 ETKDGv3 11 FFO C8A -5.291 -0.343 -1.532 ETKDGv3 12 FFO C9 -3.073 -1.045 2.145 ETKDGv3 13 FFO N10 -1.784 -1.728 2.000 ETKDGv3 14 FFO C11 1.921 0.059 0.786 ETKDGv3 15 FFO C12 0.871 0.837 1.107 ETKDGv3 16 FFO C13 -0.411 0.238 1.532 ETKDGv3 17 FFO C14 -0.554 -1.100 1.587 ETKDGv3 18 FFO C15 0.597 -1.959 1.222 ETKDGv3 19 FFO C16 1.760 -1.417 0.841 ETKDGv3 20 FFO C 3.206 0.665 0.362 ETKDGv3 21 FFO O 3.214 1.833 -0.117 ETKDGv3 22 FFO N 4.443 -0.053 0.499 ETKDGv3 23 FFO CA 5.694 0.437 -0.089 ETKDGv3 24 FFO CB 6.895 -0.353 0.475 ETKDGv3 25 FFO CG 8.260 0.176 0.005 ETKDGv3 26 FFO CD 8.534 1.554 0.525 ETKDGv3 27 FFO OE1 8.901 1.717 1.719 ETKDGv3 28 FFO OE2 8.352 2.657 -0.304 ETKDGv3 29 FFO CT 5.624 0.306 -1.585 ETKDGv3 30 FFO O1 5.865 1.302 -2.318 ETKDGv3 31 FFO O2 5.306 -0.920 -2.163 ETKDGv3 32 FFO C5A -5.780 0.142 2.021 ETKDGv3 33 FFO O5B -5.277 0.396 3.146 ETKDGv3 34 FFO HN21 -7.054 0.564 -5.067 ETKDGv3 35 FFO HN22 -8.001 1.939 -4.397 ETKDGv3 36 FFO H6 -2.932 0.090 0.308 ETKDGv3 37 FFO H7 -2.764 -2.277 -0.363 ETKDGv3 38 FFO H91 -2.939 -0.164 2.806 ETKDGv3 39 FFO H92 -3.787 -1.738 2.642 ETKDGv3 40 FFO HN0 -1.768 -2.756 2.191 ETKDGv3 41 FFO H12 0.950 1.917 1.078 ETKDGv3 42 FFO H13 -1.215 0.906 1.803 ETKDGv3 43 FFO H15 0.494 -3.036 1.248 ETKDGv3 44 FFO H16 2.569 -2.072 0.548 ETKDGv3 45 FFO HN 4.460 -0.926 1.074 ETKDGv3 46 FFO HA 5.816 1.507 0.188 ETKDGv3 47 FFO HB1 6.863 -0.322 1.587 ETKDGv3 48 FFO HB2 6.808 -1.421 0.177 ETKDGv3 49 FFO HG1 9.055 -0.507 0.373 ETKDGv3 50 FFO HG2 8.316 0.175 -1.104 ETKDGv3 51 FFO HOE2 8.520 3.596 0.037 ETKDGv3 52 FFO HO2 5.260 -1.023 -3.170 ETKDGv3 53 FFO H5A -6.857 0.053 1.945 ETKDGv3 54 FFO H22 -7.792 2.544 -1.983 ETKDGv3 55 FFO H23 -4.414 -2.611 0.290 ETKDGv3 56 FFO H24 -4.147 -1.988 -2.301 ETKDGv3 57 #